The Recall Desk

FDA (Drugs) recall action 83457

Johnson Matthey Inc. recalled 3 products on 2019-10-02

The FDA (Drugs) publishes a recall like this one as 3 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 3 pages.

Products
3
Announced
2019-10-02
Critical
0
Units
—

Why these products were recalled

cGMP Deviations: Potential glass contamination

The agency’s own wording, quoted from the enforcement report.

1–3 of 3

  • ModerateFDA (Drugs)··2019-10-02

    FDA Recalls Oxaliplatin Active Pharmaceutical Ingredient Due to Glass Contamination

    Johnson Matthey Inc. is recalling Oxaliplatin Active Pharmaceutical Ingredient due to potential glass contamination. The product was distributed nationwide in the United States.

    Product
    Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX
    Category
    Distribution
    0 states
  • ModerateFDA (Drugs)··2019-10-02

    Fentanyl Citrate Ingredient Recalled for Potential Glass Contamination

    Johnson Matthey Inc. is recalling fentanyl citrate active pharmaceutical ingredient due to potential glass contamination.

    Product
    Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.
    Category
    Distribution
    0 states